| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 570 | $80 | $43.1K |
| J0897 | Injection, denosumab, 1 mg | 1,980 | $20 | $35.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 300 | $50 | $15.9K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 120 | $80 | $8.7K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 60 | $120 | $6.5K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 20 | $270 | $6.2K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 630 | $10 | $4.4K |
| G0008 | Administration of influenza virus vaccine | 140 | $30 | $3.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 30 | $120 | $3.6K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 30 | $130 | $3.3K |